For the year ending 2025-12-31, CATX has $266,972K in assets. $59,941K in debts. $30,629K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 30,629 | |||
| Short-term investments | 114,108 | |||
| Accounts receivable, net of allowance for doubtful accounts 375 and 543 | 6 | |||
| Prepaid expenses and other current assets | 3,646 | |||
| Total current assets | 148,389 | |||
| Property and equipment, gross | 82,801 | |||
| Less accumulated depreciation | 6,204 | |||
| Property and equipment, net | 76,597 | |||
| Right-of-use asset, net | 1,500 | |||
| Intangible assets, in-process research and development | 40,000 | |||
| Other assets, net | 486 | |||
| Total assets | 266,972 | |||
| Accounts payable and accrued expenses | 20,511 | |||
| Lease liability | 623 | |||
| Accrued personnel expenses | 7,489 | |||
| Note payable | 56 | |||
| Deferred income (note 3) | 0 | |||
| Total current liabilities | 28,679 | |||
| Lease liability, net of current portion | 1,005 | |||
| Note payable, net of current portion | 1,569 | |||
| Deferred income, net of current portion (note 3) | 26,600 | |||
| Deferred tax liability | 1,702 | |||
| Other noncurrent liabilities | 386 | |||
| Total liabilities | 59,941 | |||
| Common stock 0.001 par value authorized 750,000,000 shares issued 74,337,990 and 70,671,464 shares | 74 | |||
| Additional paid-in capital | 541,687 | |||
| Accumulated other comprehensive income (loss) | 110 | |||
| Accumulated deficit | -334,840 | |||
| Total stockholders' equity | 207,031 | |||
| Total liabilities and stockholders' equity | 266,972 | |||
Perspective Therapeutics, Inc. (CATX)
Perspective Therapeutics, Inc. (CATX)